Filing Details

Accession Number:
0001835830-24-000062
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-17 16:40:20
Reporting Period:
2024-05-15
Accepted Time:
2024-05-17 16:40:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1835830 Klaviyo Inc. KVYO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1673606 Susan Ledger St. C/O Klaviyo, Inc.
125 Summer Street, 6Th Floor
Boston MA 02110
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Series A Common Stock Acquisiton 2024-05-16 10,500 $0.00 10,500 No 4 C Direct
Series A Common Stock Disposition 2024-05-16 10,500 $24.66 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Series A Common Stock Series B Common Stock Disposition 2024-05-15 10,500 $0.00 10,500 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
59,500 No 4 C Direct
Footnotes
  1. Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into Series A Common Stock upon the occurrence of certain events set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date.
  2. These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023.
  3. Consists of (i) 12,833 shares of Series B Common Stock and (ii) 46,667 unvested restricted stock units awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement.